DK0839036T3 - Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge - Google Patents

Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge

Info

Publication number: DK0839036T3
Authority: DK; Denmark
Prior art keywords: arterial walls; therapy; prevention; lercanidipine; atherosclerotic
Prior art date: 1995-07-14

Application number

DK96924834T

Other languages

English (en)

Inventor

Amedeo Leonardi

Rodolfo Testa

Original Assignee

Recordati Chem Pharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-14

Filing date

1996-06-28

Publication date

2000-01-24

1996-06-28 Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm

2000-01-24 Application granted granted Critical

2000-01-24 Publication of DK0839036T3 publication Critical patent/DK0839036T3/da

Links

YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title abstract 3
230000003143 atherosclerotic effect Effects 0.000 title abstract 3
230000015556 catabolic process Effects 0.000 title abstract 2
238000006731 degradation reaction Methods 0.000 title abstract 2
230000002265 prevention Effects 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
ZDXUKAKRHYTAKV-MGBGTMOVSA-N 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl (4r)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1([C@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-MGBGTMOVSA-N 0.000 abstract 1
ZDXUKAKRHYTAKV-XIFFEERXSA-N 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1([C@@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-XIFFEERXSA-N 0.000 abstract 1
102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
108010007622 LDL Lipoproteins Proteins 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
ZDXUKAKRHYTAKV-UHFFFAOYSA-N lercanidipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-UHFFFAOYSA-N 0.000 abstract 1
229960004294 lercanidipine Drugs 0.000 abstract 1
210000002540 macrophage Anatomy 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000004060 metabolic process Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000013508 migration Methods 0.000 abstract 1
230000005012 migration Effects 0.000 abstract 1
238000012986 modification Methods 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
210000000107 myocyte Anatomy 0.000 abstract 1
230000001590 oxidative effect Effects 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
231100000216 vascular lesion Toxicity 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

DK96924834T 1995-07-14 1996-06-28 Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge DK0839036T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITMI951513A IT1275532B (it)	1995-07-14	1995-07-14	Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
PCT/EP1996/002872 WO1997003669A1 (en)	1995-07-14	1996-06-28	Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls

Publications (1)

Publication Number	Publication Date
DK0839036T3 true DK0839036T3 (da)	2000-01-24

Family

ID=11371972

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96924834T DK0839036T3 (da)	1995-07-14	1996-06-28	Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge

Country Status (19)

Country	Link
EP (1)	EP0839036B1 (da)
JP (1)	JPH11509214A (da)
KR (1)	KR19990028741A (da)
CN (1)	CN1190345A (da)
AT (1)	ATE183644T1 (da)
AU (1)	AU690471B2 (da)
CA (1)	CA2219501A1 (da)
CZ (1)	CZ11698A3 (da)
DE (1)	DE69603968T2 (da)
DK (1)	DK0839036T3 (da)
ES (1)	ES2138359T3 (da)
GR (1)	GR3031096T3 (da)
HU (1)	HUP9802736A3 (da)
IL (1)	IL122302A (da)
IT (1)	IT1275532B (da)
NO (1)	NO980171D0 (da)
SK (1)	SK4198A3 (da)
WO (1)	WO1997003669A1 (da)
ZA (1)	ZA965924B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20011726A1 (it) *	2001-08-06	2003-02-06	Recordati Ind Chimica E Farma	Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en)	2001-08-06	2005-02-08	Recordati Ireland Limited	Crude and crystalline forms of lercanidipine hydrochloride
TW200613275A (en)	2004-08-24	2006-05-01	Recordati Ireland Ltd	Lercanidipine salts
AR053023A1 (es) *	2005-02-25	2007-04-18	Recordati Ireland Ltd	Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
SI2585051T2 (sl)	2010-06-23	2020-07-31	Krka, D.D., Novo Mesto	Farmacevtske oralne odmerne oblike,ki obsegajo lerkanidipin in enalapril in njune farmacevtsko sprejemljive soli
US8658676B2 (en)	2010-10-12	2014-02-25	The Medicines Company	Clevidipine emulsion formulations containing antimicrobial agents
HUE026295T2 (en)	2010-10-12	2016-06-28	The Medicines Co	Clevidipine emulsion formulations containing antimicrobial agents
EA023996B1 (ru)	2010-12-24	2016-08-31	КРКА, д.д., НОВО МЕСТО	Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацевтически приемлемые соли совместно с органической кислотой

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8403866D0 (en) *	1984-02-14	1984-03-21	Recordati Chem Pharm	Diphenylalkylaminoalkyl esters

1995
- 1995-07-14 IT ITMI951513A patent/IT1275532B/it active IP Right Grant
1996
- 1996-06-28 IL IL12230296A patent/IL122302A/xx not_active IP Right Cessation
- 1996-06-28 JP JP9506222A patent/JPH11509214A/ja active Pending
- 1996-06-28 AU AU65164/96A patent/AU690471B2/en not_active Ceased
- 1996-06-28 DE DE69603968T patent/DE69603968T2/de not_active Expired - Fee Related
- 1996-06-28 AT AT96924834T patent/ATE183644T1/de not_active IP Right Cessation
- 1996-06-28 WO PCT/EP1996/002872 patent/WO1997003669A1/en not_active Ceased
- 1996-06-28 CZ CZ98116A patent/CZ11698A3/cs unknown
- 1996-06-28 DK DK96924834T patent/DK0839036T3/da active
- 1996-06-28 ES ES96924834T patent/ES2138359T3/es not_active Expired - Lifetime
- 1996-06-28 KR KR1019980700039A patent/KR19990028741A/ko not_active Withdrawn
- 1996-06-28 CA CA002219501A patent/CA2219501A1/en not_active Abandoned
- 1996-06-28 HU HU9802736A patent/HUP9802736A3/hu unknown
- 1996-06-28 EP EP96924834A patent/EP0839036B1/en not_active Expired - Lifetime
- 1996-06-28 SK SK41-98A patent/SK4198A3/sk unknown
- 1996-06-28 CN CN96195439A patent/CN1190345A/zh active Pending
- 1996-07-12 ZA ZA965924A patent/ZA965924B/xx unknown
1998
- 1998-01-14 NO NO980171A patent/NO980171D0/no not_active Application Discontinuation
1999
- 1999-08-26 GR GR990402179T patent/GR3031096T3/el unknown

Also Published As

Publication number	Publication date
CA2219501A1 (en)	1997-02-06
EP0839036A1 (en)	1998-05-06
ES2138359T3 (es)	2000-01-01
WO1997003669A1 (en)	1997-02-06
CN1190345A (zh)	1998-08-12
IL122302A (en)	2000-08-13
GR3031096T3 (en)	1999-12-31
HUP9802736A3 (en)	2000-03-28
IL122302A0 (en)	1998-04-05
ITMI951513A0 (it)	1995-07-14
IT1275532B (it)	1997-08-07
AU690471B2 (en)	1998-04-23
EP0839036B1 (en)	1999-08-25
CZ11698A3 (cs)	1998-06-17
ATE183644T1 (de)	1999-09-15
NO980171L (no)	1998-01-14
DE69603968D1 (de)	1999-09-30
NO980171D0 (no)	1998-01-14
AU6516496A (en)	1997-02-18
DE69603968T2 (de)	2000-04-06
JPH11509214A (ja)	1999-08-17
ZA965924B (en)	1997-01-30
KR19990028741A (ko)	1999-04-15
SK4198A3 (en)	1998-05-06
ITMI951513A1 (it)	1997-01-14
HUP9802736A2 (hu)	1999-03-29

Similar Documents

Publication	Publication Date	Title
EP0659211A4 (en)	1996-02-07	METHOD AND THERAPEUTIC COMPOSITIONS FOR TREATING CYSTIC FIBROSE.
NO307827B1 (no)	2000-06-05	Benzoksazol- og pyridinderivater, anvendelse av dem og farmasøytisk preparat inneholdende dem
FI952536A7 (fi)	1996-09-22	Glukagonia muistuttavia insulinotrooppisia komplekseja, koostumuksia ja menetelmiä
AR017639A1 (es)	2001-09-12	Procedimiento de la alquilacion directa en una etapa, en las posiciones 7 y 10 simultaneamente de las dos funciones hidroxilos de la 10-desacetilbacatina o de los derivados de esta ultima esterificados en la posicion 13.
NO974685D0 (no)	1997-10-10	Acetamidderivater, fremgangsmåte for fremstilling av disse, og farmasöytisk preparat inneholdende disse
NO975987D0 (no)	1997-12-19	4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO976128L (no)	1998-02-10	Forbindelser og farmasöytiske blandinger som inneholder dem
DE69914854D1 (de)	2004-03-25	Sulfoxidderivate und Acetonkomplexe und Verfahren zu ihrer Herstellung
DE69430170D1 (de)	2002-04-25	Pektin, Verfahren und Zusammensetzung
AU6914296A (en)	1997-03-27	Left coronary artery catheter
FR2695826B1 (fr)	1995-01-06	Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
ATA900894A (de)	2001-04-15	Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
DK0839036T3 (da)	2000-01-24	Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge
FR2753449B1 (fr)	1998-12-04	Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
NO961000D0 (no)	1996-03-12	Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
FR2769311B1 (fr)	1999-12-24	Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique
NO306114B1 (no)	1999-09-20	Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem
IS4809A (is)	1998-07-24	Taxóíð, efnasmíði þeirra og lyfjasamsetning sem inniheldur þau
NO975365D0 (no)	1997-11-21	Benzopyraner og farmasöytiske sammensetninger inneholdende dem
NO973401D0 (no)	1997-07-23	Kortikosteroidinneholdende sammensetninger og fremstilling derav
TW372962B (en)	1999-11-01	Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient
FR2725720B1 (fr)	1997-01-03	Derives metalloceniques du diarylethylene, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits derives
NO953322L (no)	1996-02-26	Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
ITFI920134A1 (it)	1993-12-22	Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
IT1285093B1 (it)	1998-06-03	Composizione farmaceutica per malattie cardiovascolari e renali.